Work

The efficacy of bevacizumab plus erlotinib (B+E) in patients (pts) with renal medullary carcinoma (RMC).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.303

Authors: Andrew James Wiele, Devaki Shilpa Surasi, Priya Rao, Kanishka Sircar, Tharakeswara Bathala, Amishi Yogesh Shah, Eric Jonasch, Vince David Cataldo, Giannicola Genovese, Jose A. Karam, Christopher G. Wood, Nizar M. Tannir, Pavlos Msaouel

Institutions: The University of Texas MD Anderson Cancer Center, Mary Bird Perkins Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3133725868

Cites:

Cited by: 3

Related to: 10